Zheyu Dong
State Key Laboratory Of Organ Failure Research, Key Laboratory Of Infectious Diseases Research In South China, Guangdong Provincial Key Laboratory For Prevention And Control Of Major Liver Diseases
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
PPARα activation overcomes fibroinflammatory liver microenvironment-associated anti-PD-1 resistance in hepatocellular carcinoma by mediating GSDME-dependent pyroptosis.
Journal: Nature communications
Published: September 22, 2025
IL-21 attenuates liver inflammation by enhancing myeloid-derived suppressor cells immunosuppressive function in chronic HBV infection.
Journal: Journal of translational medicine
Published: June 02, 2025
The LUBAC subunit HOIL-1 promotes the progression of HBV-associated hepatocellular carcinoma independently of linear ubiquitination.
Journal: Experimental & molecular medicine
Published: December 23, 2024
Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC.
Journal: Hepatology (Baltimore, Md.)
Published: April 25, 2023
HBV Core-specific CD4+ T cells correlate with sustained viral control upon off-treatment in HBeAg-positive chronic hepatitis B patients.
Journal: Antiviral research
Published: October 29, 2022
Differential response of HBV envelope-specific CD4 + T cells is related to HBsAg loss after stopping nucleos(t)ide analogue therapy.
Journal: Hepatology (Baltimore, Md.)
Published: May 15, 2022
Dihydroartemisinin alleviates atopic dermatitis in mice by inhibiting mast cell infiltration
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: October 29, 2020
Vascular endothelial Cdc42 deficiency delays skin wound-healing processes by increasing IL-1β and TNF-α expression.
Journal: American journal of translational research
Published: May 08, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026